Clinical Research Directory
Browse clinical research sites, groups, and studies.
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations
Sponsor: Shandong University
Summary
The purpose of this study is to describe the population pharmacokinetic characteristics of piperacillin/tazobactam after intravenous administration in pregnant women during pregnancy and delivery, and to evaluate pharmacodynamic effectiveness and safety of piperacillin/tazobactam in pregnant women whose baby are at high risk of developing early-onset sepsis after birth.
Official title: Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations With High Risk for EOS
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2023-09-30
Completion Date
2026-12-31
Last Updated
2023-10-10
Healthy Volunteers
No
Conditions
Interventions
Piperacillin Sodium and Tazobactam Sodium for Injection
Piperacillin/Tazobactam, specification: 4g; 0.5g. Anti-infective therapy with piperacillin/tazobactam, specific regimen based on clinical practice, without intervention.
Locations (1)
Shandong Provincial Hospital
Jinan, China